...
首页> 外文期刊>Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia >Stereotactic radiosurgery of meningiomas following resection: Predictors of progression
【24h】

Stereotactic radiosurgery of meningiomas following resection: Predictors of progression

机译:切除后脑膜瘤的立体定向放射外科:进展的预测因子

获取原文
获取原文并翻译 | 示例
           

摘要

Residual or recurrent meningiomas after initial surgical resection are commonly treated with stereotactic radiosurgery (SRS), but progression of these tumors following radiosurgery is difficult to predict. We performed a retrospective review of 60 consecutive patients who underwent resection and subsequent Gamma Knife (Elekta AB, Stockholm, Sweden) radiosurgery for residual or recurrent meningiomas at our institution from 2001-2012. Patients were subdivided by Simpson resection grade and World Health Organization (WHO) grade. Cox multivariate regression and Kaplan-Meier analyses were performed to assess risk of tumor progression. There were 45 men (75%) and 15 women (25%) with a median age of 56.8 years (range 26.5-82 years). The median follow-up period was 34.9 months (range 6-108.4 months). Simpson grade 1-3 resection was achieved in 17 patients (28.3%) and grade 4 resection in 43 patients (71.7%). Thirty-four tumors (56.7%) were WHO grade 1, and 22 (36.7%) were WHO grade 2-3. Time from resection to SRS was significantly shorter in patients with Simpson grade 4 resection compared to grade 1-3 resection (p < 0.01), but did not differ by WHO grade (p = 0.17). Post-SRS complications occurred in five patients (8.3%). Overall, 19 patients (31.7%) experienced progression at a median of 153 months (range 1.2-61.4 months). Maximum tumor diameter >2.5 cm at the time of SRS (p = 0.02) and increasing WHO grade (p < 0.01) were predictive of progression in multivariate analysis. Simpson resection grade did not affect progression-free survival (p = 0.90). The mortality rate over the study period was 8.3%. SRS offers effective tumor control for residual or recurrent meningiomas following resection, especially for small benign tumors. (C) 2014 Elsevier Ltd. All rights reserved.
机译:初次手术切除后残留或复发性脑膜瘤通常采用立体定向放射外科手术(SRS)进行治疗,但是这些肿瘤在放射外科手术后的进展难以预测。我们对2001年至2012年间60例连续切除并随后接受伽玛刀(Elekta AB,斯德哥尔摩,瑞典)的放射外科手术患者的残留或复发性脑膜瘤进行了回顾性研究。根据辛普森切除术等级和世界卫生组织(WHO)等级对患者进行细分。进行Cox多元回归和Kaplan-Meier分析以评估肿瘤进展的风险。有45位男性(75%)和15位女性(25%),中位年龄为56.8岁(范围26.5-82岁)。中位随访期为34.9个月(范围6-108.4个月)。 17例患者(28.3%)达到Simpson 1-3级切除,43例患者(71.7%)实现4级切除。 WHO分级为34例(56.7%),WHO 2-3级为22例(36.7%)。与1-3级切除相比,Simpson 4级切除患者从切除到SRS的时间明显缩短(p <0.01),但在WHO分类中没有差异(p = 0.17)。 SRS后并发症发生在五名患者(8.3%)中。总体而言,有19名患者(31.7%)经历了平均153个月(1.2-61.4个月)的进展。 SRS时最大肿瘤直径> 2.5 cm(p = 0.02)和WHO分级增加(p <0.01)可预测多变量分析的进展。辛普森切除术等级不影响无进展生存期(p = 0.90)。研究期间的死亡率为8.3%。 SRS为切除后残留或复发性脑膜瘤提供有效的肿瘤控制,尤其是对于小的良性肿瘤。 (C)2014 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号